analytics_image
Access TOC - Personalized Healthcare Market 2025\
Vantage Market Research
Vantage Market Research

Reports - Personalized Healthcare Market

iconHealthcare

Personalized Healthcare Market

Personalized Healthcare Market Valuation and Future Projections to 2035 by Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Nutrition & Wellness) by Technology (Next-Generation Sequencing (NGS), Big Data Analytics, Bioinformatics, Drug Discovery, Companion Diagnostics) by Application (Oncology, Central Nervous System (CNS), Immunology, Respiratory, Others) by End-User (Hospitals, Specialty Clinics, Home Healthcare) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Table of Contents

Chapter 1   Executive Dashboard
1. Strategic Imperatives
Chapter 2   Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3   Global Personalized Healthcare Market - Segment Analysis
1. Overview
2. Global Personalized Healthcare Market, 2021 - 2035 (USD Million)
3. Global Personalized Healthcare Market - by Product
3.1. By Personalized Medicine Diagnostics
3.2. By Personalized Medicine Therapeutics
3.3. By Personalized Nutrition & Wellness
4. Global Personalized Healthcare Market - by Technology
4.1. By Next-Generation Sequencing (NGS)
4.2. By Big Data Analytics
4.3. By Bioinformatics
4.4. By Drug Discovery
4.5. By Companion Diagnostics
5. Global Personalized Healthcare Market - by Application
5.1. By Oncology
5.2. By Central Nervous System (CNS)
5.3. By Immunology
5.4. By Respiratory
5.5. By Others
6. Global Personalized Healthcare Market - by End-User
6.1. By Hospitals
6.2. By Specialty Clinics
6.3. By Home Healthcare
7. Global Personalized Healthcare Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4   North America Personalized Healthcare Market - Segment Analysis
1. Overview
2. North America Personalized Healthcare Market, 2021 - 2035 (USD Million)
3. North America Personalized Healthcare Market - by Product
3.1. By Personalized Medicine Diagnostics
3.2. By Personalized Medicine Therapeutics
3.3. By Personalized Nutrition & Wellness
4. North America Personalized Healthcare Market - by Technology
4.1. By Next-Generation Sequencing (NGS)
4.2. By Big Data Analytics
4.3. By Bioinformatics
4.4. By Drug Discovery
4.5. By Companion Diagnostics
5. North America Personalized Healthcare Market - by Application
5.1. By Oncology
5.2. By Central Nervous System (CNS)
5.3. By Immunology
5.4. By Respiratory
5.5. By Others
6. North America Personalized Healthcare Market - by End-User
6.1. By Hospitals
6.2. By Specialty Clinics
6.3. By Home Healthcare
Chapter 5   Europe Personalized Healthcare Market - Segment Analysis
1. Overview
2. Europe Personalized Healthcare Market, 2021 - 2035 (USD Million)
3. Europe Personalized Healthcare Market - by Product
3.1. By Personalized Medicine Diagnostics
3.2. By Personalized Medicine Therapeutics
3.3. By Personalized Nutrition & Wellness
4. Europe Personalized Healthcare Market - by Technology
4.1. By Next-Generation Sequencing (NGS)
4.2. By Big Data Analytics
4.3. By Bioinformatics
4.4. By Drug Discovery
4.5. By Companion Diagnostics
5. Europe Personalized Healthcare Market - by Application
5.1. By Oncology
5.2. By Central Nervous System (CNS)
5.3. By Immunology
5.4. By Respiratory
5.5. By Others
6. Europe Personalized Healthcare Market - by End-User
6.1. By Hospitals
6.2. By Specialty Clinics
6.3. By Home Healthcare
Chapter 6   Asia Pacific Personalized Healthcare Market - Segment Analysis
1. Overview
2. Asia Pacific Personalized Healthcare Market, 2021 - 2035 (USD Million)
3. Asia Pacific Personalized Healthcare Market - by Product
3.1. By Personalized Medicine Diagnostics
3.2. By Personalized Medicine Therapeutics
3.3. By Personalized Nutrition & Wellness
4. Asia Pacific Personalized Healthcare Market - by Technology
4.1. By Next-Generation Sequencing (NGS)
4.2. By Big Data Analytics
4.3. By Bioinformatics
4.4. By Drug Discovery
4.5. By Companion Diagnostics
5. Asia Pacific Personalized Healthcare Market - by Application
5.1. By Oncology
5.2. By Central Nervous System (CNS)
5.3. By Immunology
5.4. By Respiratory
5.5. By Others
6. Asia Pacific Personalized Healthcare Market - by End-User
6.1. By Hospitals
6.2. By Specialty Clinics
6.3. By Home Healthcare
Chapter 7   Latin America Personalized Healthcare Market - Segment Analysis
1. Overview
2. Latin America Personalized Healthcare Market, 2021 - 2035 (USD Million)
3. Latin America Personalized Healthcare Market - by Product
3.1. By Personalized Medicine Diagnostics
3.2. By Personalized Medicine Therapeutics
3.3. By Personalized Nutrition & Wellness
4. Latin America Personalized Healthcare Market - by Technology
4.1. By Next-Generation Sequencing (NGS)
4.2. By Big Data Analytics
4.3. By Bioinformatics
4.4. By Drug Discovery
4.5. By Companion Diagnostics
5. Latin America Personalized Healthcare Market - by Application
5.1. By Oncology
5.2. By Central Nervous System (CNS)
5.3. By Immunology
5.4. By Respiratory
5.5. By Others
6. Latin America Personalized Healthcare Market - by End-User
6.1. By Hospitals
6.2. By Specialty Clinics
6.3. By Home Healthcare
Chapter 8   Middle East & Africa Personalized Healthcare Market - Segment Analysis
1. Overview
2. Middle East & Africa Personalized Healthcare Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Personalized Healthcare Market - by Product
3.1. By Personalized Medicine Diagnostics
3.2. By Personalized Medicine Therapeutics
3.3. By Personalized Nutrition & Wellness
4. Middle East & Africa Personalized Healthcare Market - by Technology
4.1. By Next-Generation Sequencing (NGS)
4.2. By Big Data Analytics
4.3. By Bioinformatics
4.4. By Drug Discovery
4.5. By Companion Diagnostics
5. Middle East & Africa Personalized Healthcare Market - by Application
5.1. By Oncology
5.2. By Central Nervous System (CNS)
5.3. By Immunology
5.4. By Respiratory
5.5. By Others
6. Middle East & Africa Personalized Healthcare Market - by End-User
6.1. By Hospitals
6.2. By Specialty Clinics
6.3. By Home Healthcare
Chapter 9   Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10   COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11   Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12   Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13   Company Profiles
1. Illumina Inc.
2. GE Healthcare
3. AstraZeneca plc
4. Abbott
5. Thermo Fisher Scientific
6. Pfizer Inc.
7. Novartis AG
8. Bayer AG
9. Bristol-Myers Squibb Company
10. 23andMe Inc.
11. Foundation Medicine
Chapter 14   Key Primary Respondents - VERBATIM
Chapter 15   Discussion Guide
Chapter 16   Customization Offered
Chapter 17   Annexure
Chapter 18   List of Figures
Chapter 19   List of Tables
Chapter 20   List of Abbreviations

FAQ‘s

Related Reports

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by